(1)
Celecoxib and Rofecoxib: Efficacy and Safety of Selective Inhibitors of Cox-2 Compared to Non-Selective NSAIDs. Rev Port Med Geral Fam 2004, 20 (1), 47-64. https://doi.org/10.32385/rpmgf.v20i1.10008.